JP2024040951A5 - - Google Patents

Info

Publication number
JP2024040951A5
JP2024040951A5 JP2022145626A JP2022145626A JP2024040951A5 JP 2024040951 A5 JP2024040951 A5 JP 2024040951A5 JP 2022145626 A JP2022145626 A JP 2022145626A JP 2022145626 A JP2022145626 A JP 2022145626A JP 2024040951 A5 JP2024040951 A5 JP 2024040951A5
Authority
JP
Japan
Prior art keywords
solid dispersion
apalutamide
enzalutamide
pharmaceutical composition
hesperidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022145626A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024040951A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2022145626A priority Critical patent/JP2024040951A/ja
Priority claimed from JP2022145626A external-priority patent/JP2024040951A/ja
Publication of JP2024040951A publication Critical patent/JP2024040951A/ja
Publication of JP2024040951A5 publication Critical patent/JP2024040951A5/ja
Pending legal-status Critical Current

Links

JP2022145626A 2022-09-13 2022-09-13 アンドロゲン受容体アンタゴニストの固体分散体を含む薬学的組成物 Pending JP2024040951A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022145626A JP2024040951A (ja) 2022-09-13 2022-09-13 アンドロゲン受容体アンタゴニストの固体分散体を含む薬学的組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2022145626A JP2024040951A (ja) 2022-09-13 2022-09-13 アンドロゲン受容体アンタゴニストの固体分散体を含む薬学的組成物

Publications (2)

Publication Number Publication Date
JP2024040951A JP2024040951A (ja) 2024-03-26
JP2024040951A5 true JP2024040951A5 (https=) 2025-09-22

Family

ID=90369106

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022145626A Pending JP2024040951A (ja) 2022-09-13 2022-09-13 アンドロゲン受容体アンタゴニストの固体分散体を含む薬学的組成物

Country Status (1)

Country Link
JP (1) JP2024040951A (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025052925A1 (ja) * 2023-09-08 2025-03-13 沢井製薬株式会社 エンザルタミド固体分散体及びその製造方法、並びにエンザルタミド含有製剤及びその製造方法
TR2024004340A1 (tr) * 2024-04-05 2025-10-21 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Enzalutamidin katı dispersiyonu.

Similar Documents

Publication Publication Date Title
AU2005324132B2 (en) Solid, orally applicable pharmaceutical administration forms containing rivaroxaban having modified release
EP0381219B1 (en) Modified release gemfibrozil composition
JP4749639B2 (ja) 味がマスクされ、活性成分を即時放出する、被覆された顆粒の製造方法
RU2542461C2 (ru) Фармацевтические композиции, содержащие диацереин
IT9019571A1 (it) Composizioni terapeutiche a rilascio controllato di farmaci supportati su polimeri reticolati e rivestiti con film polimerici, e loro processo di preparazione
JP2009530415A5 (https=)
JP2009502487A5 (https=)
JP2024040951A5 (https=)
JP2001520985A (ja) 浸透圧性薬剤放出系
JP2007517050A5 (https=)
EP0381218B1 (en) Extended release gemfibrozil composition
US20090324728A1 (en) Pharmaceutical compositions comprising amorphous benzimidazole compounds
JP3017040B2 (ja) トリメタジジンの経口投与用持続的放出型薬剤組成物
WO2011160541A1 (zh) 托伐普坦固体分散体及其制备方法
WO2015145462A1 (en) Pharmaceutical compositions of dabigatran
JPS6248618A (ja) 徐放性製剤およびその製造法
WO1997033574A1 (fr) Comprimes a liberation prolongee a base de valproate metallique
KR20110113940A (ko) 탐술로신 또는 이의 약제학적 허용 가능한 염을 유효성분으로 한 장용성 서방형 펠렛부와 속방부로 이루어진 의약 조성물
WO2017125856A1 (en) Formulations in modified-release tablets containing high-dosage mesalazine, process for their preparation and their use
JP2020519669A5 (https=)
WO2010089775A2 (en) Improved drug dosage form for controlled delivery of one or more pharmaceutically active agent
CN106999442A (zh) 用于制备药物‑聚合物组合物的方法
RU2024110714A (ru) Фармацевтические композиции на основе дидрогестерона с пролонгированным высвобождением
CN100496486C (zh) 一种难溶性药物的控释制剂
CZ300698B6 (cs) Tableta s obsahem metforminu